Published in Gene Therapy Weekly, November 15th, 2001
PowderJect already holds extensive granted European and U.S. patents covering powder injection of DNA vaccines, giving the company exclusive coverage of this unique immunization technology. Importantly, the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.